DRCAL, good to see you back ... as a long time real shareholder, I remember your inspiring expert predictions from the past ..... remember when you posted these gems:
The low cost of DNA production will almost guarantee the interest of large biotech companies, and it will become a big revenue maker for CYGX. CYGX said that three companies were already interested. As soon as contract or licensing agreements are up with other DNA producers, CYGX could have all companies, even competitors, on board for licensing.
and how about the accuracy of this prediction of how our fortunes would soon be made ....
This is no longer 2003. The science is getting recognition from professional researchers who are probably the current buyers. Licensing of the DNA production technology should bring in millions. For myself, I bought, then I doubted, then sold, until I was reassured and finally bought back at a higher price.
I'll stay with my $5.00 prediction because times have changed and the science is maturing. Meanwhile, I think that most investors will bail out at $1.00 soon.